Controlled Clinical Trials as Topic [klinické zkoušky kontrolované jako téma]

topical
165
Terms

Clinical Trials, Controlled as Topic

Persistent link   https://www.medvik.cz/link/D018849
Definition

Works about clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS AS TOPIC.

Annotation
for general design, methodology, economics, etc. of clinical trials; a different heading CONTROLLED CLINICAL TRIAL is used for reports of a specific clinical trial
DUI
D018849 MeSH Browser
CUI
M0028203
Previous indexing
Clinical Trials (1980-1994)
History note
2008(1995); use CLINICAAL TRIALS 1980-1984
Public note
2008; see CONTROLLED CLINICAL TRIALS 1995-2007,was see CLINICAL TRIALS 1980-1994

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E05.318.372.250 Clinical Studies as Topic 3 510
E05.318.372.250.250 Clinical Trials as Topic 4 867
E05.318.372.250.250.100 Adaptive Clinical Trials as Topic 2
E05.318.372.250.250.200 Clinical Trials, Phase I as Topic 173
E05.318.372.250.250.210 Clinical Trials, Phase II as Topic 492
E05.318.372.250.250.220 Clinical Trials, Phase III as Topic 1 430
E05.318.372.250.250.230 Clinical Trials, Phase IV as Topic 51
E05.318.372.250.250.365 Controlled Clinical Trials as Topic 165
E05.318.372.250.250.365.250 Non-Randomized Controlled Trials as Topic 33
E05.318.372.250.250.365.500 Randomized Controlled Trials as Topic 4 384
E05.318.372.250.250.524 Human Challenge Trials as Topic
E05.318.372.250.250.682 Single-Case Studies as Topic 2

N Health Care
N05.715.360.330.250 Clinical Studies as Topic 3 510
N05.715.360.330.250.250 Clinical Trials as Topic 4 867
N05.715.360.330.250.250.100 Adaptive Clinical Trials as Topic 2
N05.715.360.330.250.250.200 Clinical Trials, Phase I as Topic 173
N05.715.360.330.250.250.210 Clinical Trials, Phase II as Topic 492
N05.715.360.330.250.250.220 Clinical Trials, Phase III as Topic 1 430
N05.715.360.330.250.250.230 Clinical Trials, Phase IV as Topic 51
N05.715.360.330.250.250.365 Controlled Clinical Trials as Topic 165
N05.715.360.330.250.250.365.250 Non-Randomized Controlled Trials as Topic 33
N05.715.360.330.250.250.365.500 Randomized Controlled Trials as Topic 4 384
N05.715.360.330.250.250.524 Human Challenge Trials as Topic
N05.715.360.330.250.250.682 Single-Case Studies as Topic 2
N06.850 Public Health 4 058
N06.850.520 Epidemiologic Methods 1 033
N06.850.520.450.250 Clinical Studies as Topic 3 510
N06.850.520.450.250.250 Clinical Trials as Topic 4 867
N06.850.520.450.250.250.100 Adaptive Clinical Trials as Topic 2
N06.850.520.450.250.250.200 Clinical Trials, Phase I as Topic 173
N06.850.520.450.250.250.210 Clinical Trials, Phase II as Topic 492
N06.850.520.450.250.250.220 Clinical Trials, Phase III as Topic 1 430
N06.850.520.450.250.250.230 Clinical Trials, Phase IV as Topic 51
N06.850.520.450.250.250.365 Controlled Clinical Trials as Topic 165
N06.850.520.450.250.250.365.250 Non-Randomized Controlled Trials as Topic 33
N06.850.520.450.250.250.365.500 Randomized Controlled Trials as Topic 4 384
N06.850.520.450.250.250.524 Human Challenge Trials as Topic
N06.850.520.450.250.250.682 Single-Case Studies as Topic 2